Mechanistic Insight on the Mode of Action of Colletoic Acid.
Taotao LingDarcie J MillerWalter H LangElizabeth GriffithAdaris Rodriguez-CortesIkbale El AyachiGustavo PalaciosJaeki MinGustavo Miranda-CarboniRichard E LeeFatima RivasPublished in: Journal of medicinal chemistry (2019)
The natural product colletoic acid (CA) is a selective inhibitor of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), which primarily converts cortisone to the active glucocorticoid (GC) cortisol. Here, CA's mode of action and its potential as a chemical tool to study intracellular GC signaling in adipogenesis are disclosed. 11β-HSD1 biochemical studies of CA indicated that its functional groups at C-1, C-4, and C-9 were important for enzymatic activity; an X-ray crystal structure of 11β-HSD1 bound to CA at 2.6 Å resolution revealed the nature of those interactions, namely, a close-fitting and favorable interactions between the constrained CA spirocycle and the catalytic triad of 11β-HSD1. Structure-activity relationship studies culminated in the development of a superior CA analogue with improved target engagement. Furthermore, we demonstrate that CA selectively inhibits preadipocyte differentiation through 11β-HSD1 inhibition, suppressing other relevant key drivers of adipogenesis (i.e., PPARγ, PGC-1α), presumably by negatively modulating the glucocorticoid signaling pathway. The combined findings provide an in-depth evaluation of the mode of action of CA and its potential as a tool compound to study adipose tissue and its implications in metabolic syndrome.
Keyphrases
- signaling pathway
- metabolic syndrome
- adipose tissue
- insulin resistance
- skeletal muscle
- type diabetes
- high resolution
- social media
- magnetic resonance imaging
- computed tomography
- mass spectrometry
- hydrogen peroxide
- single cell
- optical coherence tomography
- pi k akt
- gas chromatography
- cardiovascular risk factors
- tandem mass spectrometry